安药业：收到化学原料药上市申请批准通知书

Core Viewpoint - Fu'an Pharmaceutical (300194) announced that its wholly-owned subsidiary Tianheng Pharmaceutical has received approval from the National Medical Products Administration for the marketing application of the chemical raw material drug Metronidazole [1] Group 1 - The approved drug Metronidazole is primarily used to treat infections caused by anaerobic bacteria, including lower respiratory tract infections, pelvic inflammatory disease, and sepsis [1]